Arcellx Raises $115m To Advance Novel T-Cell Therapies

First CAR-T In Phase I, Second Construct Heading For Clinic

 
• By Mandy Jackson
  
Coins and seeds in jars
Arcellx's series C round will fund its T-cell therapy pipeline's growth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business